alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 13,651–13,675 of 27,380 studies, newest first · page 547 of 1096.

September 2018 25

  1. 2018-09-21

    Effects of Normative Adjustments to the Montreal Cognitive Assessment

    ✓ Peer-reviewed Long-term cohort studies The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: 499 adults 48 to 91 years-old enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI) and were administered the MoCA during baseline. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2018-09-21

    The genetic landscape of Parkinson's disease

    ✓ Peer-reviewed Disparities Revue neurologique

    Key finding: GBA is a major PD risk factor often associated with dementia.

    Full summary, score breakdown and related studies → Original source

  3. 2018-09-21

    Nutrition and prevention of cognitive impairment

    ✓ Peer-reviewed Prevention and risk The Lancet. Neurology

    Key finding: For some nutrients and food groups, protection might be greater in individuals with either deficiencies in certain nutrients or a genetic predisposition to cognitive impairment. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2018-09-20

    Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau

    ✓ Peer-reviewed Drug development Acta neuropathologica

    Key finding: Clinical progression is tightly linked to the progressive spread of Tau pathology throughout the brain, and several lines of evidence suggest that Tau aggregates or "seeds" may propagate pathology by spreading from cell to cell in a "prion like" manner.

    Full summary, score breakdown and related studies → Original source

  5. 2018-09-19

    Thiamine deficiency contributes to synapse and neural circuit defects

    ✓ Peer-reviewed Disease mechanisms Biological research

    Key finding: To demonstrate this hypothesis, we established abnormalities in the glucose metabolism utilizing thiamine deficiency in vitro and in vivo, and we found dramatically reduced dendrite spine density. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2018-09-19

    Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    These estimates can be used to guide planning and interventions related to caring for the ADRD population and supporting caregivers.

    Full summary, score breakdown and related studies → Original source

  7. 2018-09-19

    Vascular risk at younger ages most strongly associates with current and future brain volume

    ✓ Peer-reviewed Long-term cohort studies Neurology

    Key finding: Given the potential therapeutic effect of vascular disease control timing to reduce dementia risk, we investigated the age-related influences of vascular risk factor burden on brain structure throughout the lifespan. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2018-09-19

    Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)

    ✓ Peer-reviewed Treatments Alzheimer's research & therapy

    Key finding: We investigated the effect of crenezumab, a humanized anti-amyloid-beta (Aβ) immunoglobulin (Ig)G4 monoclonal antibody, on biomarkers of amyloid pathology, neurodegeneration, and disease progression in patients with mild-to-moderate Alzheimer's disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2018-09-19

    Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy

    ✓ Peer-reviewed TREM2 and immune genetics Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Hemizygous missense variants in Triggering Receptor Expressed on Myeloid Cells 2 ( TREM2 ) are associated with elevated risk for developing late-onset AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2018-09-19

    Progress and future challenges in aging and diversity research in the United States

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: This report disseminates the research priorities that emerged from this conference, building on an earlier Gerontological Society of America preconference. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2018-09-17

    Understanding the Role of ApoE Fragments in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Neurochemical research

    Key finding: It has been known for decades that the APOE ɛ4 allele is the most significant genetic risk factor for late-onset AD and yet its precise role in the disease remains unclear. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2018-09-16

    Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

    ✓ Peer-reviewed How common it is The New England journal of medicine

    Key finding: Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death. +2 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2018-09-16

    The “American (cancer) patients first” plan to reduce drug prices—A critical assessment

    ✓ Peer-reviewed Health systems and care delivery American Journal of Hematology

    Key finding: Serious concerns over the rising cost of cancer drugs in the United States1-3 are increasing,4-9 following a decade during which prices rose from an average of less than $10 000/year to more than $170 000/year in 2017.10 Despite the drug industry's wish to be “part of the solution,” the problem continues to worsen.6 Between 1995 and 2013, the launch price of cancer drugs increased by 10%-12% every year.11 According to a March 2018 report, the Average Wholesale Prices of drugs increased at unprecedented rates.12 A study by Gordon and colleagues showed a 25% average annual price increase of drugs already on the market, despite competition.13 Cancer drugs spending doubled since 2013 and is expected to double again by 2022.14 This suggests that health care is different from other industries where traditional free market forces are effective in lowering prices, and that other measures are needed. +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2018-09-16

    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

    ✓ Peer-reviewed Prevention and risk The New England journal of medicine

    Key finding: After a median of 4.7 years of follow-up, the rate of cardiovascular disease was 10.7 events per 1000 person-years in the aspirin group and 11.3 events per 1000 person-years in the placebo group (hazard ratio, 0.95; 95% confidence interval [CI], 0.83 to 1.08). +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2018-09-15

    Technology-based cognitive training and rehabilitation interventions for individuals with mild cognitive impairment: a systematic review

    ✓ Peer-reviewed Prevention trials BMC geriatrics

    Key finding: Technology-based cognitive training and rehabilitation interventions show promise, but the findings were inconsistent due to the variations in study design. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2018-09-14

    Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: These longitudinal estimates clarify the sequence and temporal dynamics of presymptomatic pathologic changes in autosomal dominant AD, information critical to a better understanding of the disease. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2018-09-14

    An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: We developed, replicated, and validated an MRI measure of cerebrovascular and neurodegenerative pathologies that are associated with clinical and neuropathologic diagnosis of AD and related to established biomarkers. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2018-09-12

    Alzheimer's Disease and Rheumatoid Arthritis: A Mendelian Randomization Study

    ✓ Peer-reviewed Genetics Frontiers in neuroscience

    Key finding: Until now, it is still unclear that AD is a causally associated with RA. +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2018-09-12

    Joint Classification and Regression via Deep Multi-Task Multi-Channel Learning for Alzheimer's Disease Diagnosis

    ✓ Peer-reviewed Digital health tools IEEE transactions on bio-medical engineering

    Key finding: We evaluate the proposed method on four large multi-center cohorts with 1984 subjects, and the experimental results demonstrate that DM 2L is superior to several state-of-the-art joint learning methods in both the tasks of disease classification and clinical score regression.

    Full summary, score breakdown and related studies → Original source

  20. 2018-09-12

    Perceived barriers and facilitators in providing palliative care for people with severe dementia: the healthcare professionals' experiences

    ✓ Peer-reviewed End-of-life care BMC health services research

    Key finding: The findings indicate that healthcare professionals experienced several structural barriers that prevented the provision of palliative care to people with severe dementia in long-term care facilities. +1 more finding

    Full summary, score breakdown and related studies → Original source

  21. 2018-09-12

    Increased cerebral microbleeds and cortical superficial siderosis in pediatric patients with Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

    Key finding: In vivo MRI biomarkers can support the diagnosis of early-onset cerebral amyloid angiopathy, which might already be present in pediatric Down syndrome patients. +1 more finding

    Full summary, score breakdown and related studies → Original source

  22. 2018-09-12

    Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial

    ✓ Peer-reviewed Treatments Journal of the American Geriatrics Society

    Key finding: One hundred two (37.9%) participants were amyloid positive. +2 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2018-09-12

    Serum neurofilament light chain in behavioral variant frontotemporal dementia

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: As serum NfL correlates with functional impairment and brain atrophy in bvFTD at different disease stages, we propose it as marker of disease severity, paving the way for its future use as outcome measure for clinical trials.

    Full summary, score breakdown and related studies → Original source

  24. 2018-09-11

    Are noise and air pollution related to the incidence of dementia? A cohort study in London, England

    ✓ Peer-reviewed Risk factors BMJ open

    Key finding: We have found evidence of a positive association between residential levels of air pollution across London and being diagnosed with dementia, which is unexplained by known confounding factors. +2 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2018-09-11

    The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease

    ✓ Peer-reviewed Genetics Scientific data

    Key finding: Genetic and genome-wide association studies (GWAS) have identified about 33 risk factor genes for common, late-onset AD (LOAD), but these risk loci fail to account for the majority of affected cases and can neither provide clinically meaningful prediction of development of AD nor offer actionable mechanisms. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →